Page 65 - Bioscience Inc News Today

INVO Bioscience Advances Commercialization into the European Fertility Market with Initial Orders of INVOcell (IVC) in Spain - Spain marks INVOs initial entry into the European market - Europe represents approximately 30% of the multi-billion dollar global fertility marketplace - The first three clinics in Spain have placed initial orders for INVOcell - an effective and affordable alternative treatment for patients diagnosed with infertility News provided by Share this article SARASOTA, Fla., J...

Interview with the President and CEO: Yield10 Bioscience, Inc. (NASDAQ:YTEN) Oliver P. Peoples, Ph.D., was named President and Chief Executive Officer of Metabolix in October 2016 in conjunction with the transition to Yield10 Bioscience as the company’s core business. Dr. Peoples was a co-founder of Metabolix and served as Chief Scientific Officer from January 2000 until October 2016, and was previously Vice President of Research and Development. Dr. Peoples has served as a director since Jun...

In-seed PHA bioproduction could lead to use as a co-product with oil and protein meal. By 1/21/2021 Yield10 Bioscience, Inc., an agricultural bioscience company, has announced successful field testing of prototype lines the oilseed camelina that have been programed to produce PHA bioplastics directly in seed. PHAs are natural polymers, prevalent in nature and fully biodegradable in the environment. Currently produced by fermentation of engineered microbes, PHA polymers al...

CBD Life Sciences Inc. (CBDL) Delivers Strategic Company Overview SCOTTSDALE, AZ / ACCESSWIRE / January 20, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson announces the companys strategic overview. CBD Life Sciences Inc. has issued this strategic overview for its shareholders moving forward. Looking ahead, with its Greenhouse Facility & Grow Farm in Snowflake, Arizona, the company can expand into the Recreatio...

Covid-19 Impact on IVF Market Segmentation, Application, Technology & Industry Analysis Research Report 2027

HEXO Corp. (NASDAQ: HEXO)Canopy Growth Corporation Canopy Growth Corporation is the first cannabis company in North America to be publicly traded. Currently, Canopy is one of the largest Canadian marijuana companies in the world. With a current market cap of $12.55 billion Canopy could continue to climb in the market in January. At the present time, the company has established a few methods in entering the U.S. cannabis market. For one Canopy has begun implementation of an amended arrangement w...

Share this article SARASOTA, Fla., Jan. 15, 2021 /PRNewswire/ --  INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the worlds only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with infertility, today announced it has entered an exclusive distribution agreement with Galaxy Pharma Ltd. to distribute the INVOcell system within Pakistan. Galaxy Pharma is a leader in providing products an...

(1) KEEGO HARBOR, MI / ACCESSWIRE / January 11, 2021 / ZIVO Bioscience, Inc. (OTCQB:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of therapeutic/additive product candidates originally derived from proprietary algal cultures, announces today that in its recent analysis of two poultry studies performed at separate research facilities, ZIVO product candidates provided statistically significant feed conversion benefits in healthy broiler flocks exposed to path...

CBD Life Sciences Inc. (CBDL) Announces a Product that may Assist Autism, Depression, & PTSD SCOTTSDALE, AZ / ACCESSWIRE / January 7, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson announces a product that may assist Autism, Depression, & PTSD. CBD Life Sciences has liters upon liters of Full Spectrum Oil at its Greenhouse Facility & this is wonderful news to hear as the New Year kicks off! This also expands o...

Zivo Bioscience, Inc.: Zivo Bioscience Names Keith R. Marchiando as Chief Financial Officer KEEGO HARBOR, MI / ACCESSWIRE / January 7, 2021 / ZIVO Bioscience, Inc. (OTCMQB:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of therapeutic, food and feed additive products announced today that Keith R. Marchiando joined the Companys as Chief Financial Officer, Treasurer, and Secretary, effective January 1, 2021. "We are delighted to welcome Keith to our executive m...